Both in Surgical Instruments
Vivos Therapeutics vs NexGel
Over the past year VVOS returned −95.3% and NXGL returned −90.9%; their daily moves had a correlation of 0.06.
VVOS −95.3% NXGL −90.9%Growth of $1, one year, split-adjusted
| Metric | VVOS | NXGL |
|---|---|---|
| Price | $0.1112 | $4.01 |
| Market cap | $2.2M | $2.0M |
| Today | +1.27% | −10.49% |
| 1 month | −27.7% | +16.0% |
| 6 months | −84.6% | −66.6% |
| Year to date | −94.5% | −87.5% |
| 1 year | −95.5% | −91.5% |
| Revenue growth (YoY) | +34.9% | +27.8% |
| Gross margin | 57.3% | 30.1% |
| Net margin | −106.4% | −98.6% |
| P/E (TTM) | — | — |
| Price / sales | 0.1× | 0.2× |
| Net cash | -$6.5M | -$2.9M |
| Dividend yield | — | — |
| Volatility (60d) | 89.9% | 934.9% |
| Short % of float | 7.8% | 1.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).